These data establish ACTL6A as a key regulator of the Warburg effect in HNSCC and propose ACTL6A inhibition, either through SWI/SNF inhibition or development of a direct inhibitor, as a potential treatment strategy for HNSCC. Here, SMARCA1 is linked to head and neck squamous cell carcinoma.